Charles Cliff Duncan bought $38K of VNDA stock

Charles Cliff Duncan, Dir of Vanda Pharmaceuticals Inc. (VNDA), bought 10,000 shares of VNDA stock worth $38K, per an SEC Form 4 filed Nov 5, 2026.

It was an open-market purchase.

The trade happened on Nov 3, 2026, 2 days before it was made public.

VNDA has moved +9.1% since the trade date, from $3.75 to $4.09 (Nov 9, 2026 close).